Basaglar is indicated to improve glycaemic control ... It has the same amino acid sequence as Sanofi's blockbuster Lantus and was tentatively approved for use with KwikPen, a pre-filled dosing ...
The agreement also covered what turned into Basaglar (insulin glargine), a biosimilar of Sanofi’s big-selling Lantus for type 2 diabetes, and Trajenta (linagliptin), a DPP-4 class drug that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback